(Q62971278)

1

0 references

S.Steven Floyd

2

0 references

David K Booth

3

0 references

Thomas Oligino

4

0 references

David Krisky

5

0 references

Peggy Marconi

6

0 references

Joseph C Glorioso

7

0 references

Johnny Huard

8

0 references

J C van Deutekom

1

0 references

S S Floyd

2

0 references

D K Booth

3

0 references

T Oligino

4

0 references

D Krisky

5

0 references

P Marconi

6

0 references

J C Glorioso

7

0 references

J Huard

Systemic delivery of recombinant proteins by genetically modified myoblasts

8

0 references

language of work or name

English

0 references

publication date

May 1998

0 references

published in

Neuromuscular Disorders

0 references

volume

8

0 references

issue

3-4

0 references

page(s)

135-148

0 references

135-48

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Systemic delivery of human growth hormone by injection of genetically engineered myoblasts.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Expression of human factor IX in mice after injection of genetically modified myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Retroviral-mediated in vivo gene transfer into muscle cells and synthesis of human factor IX in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Construction of human factor IX expression vectors in retroviral vector frames optimized for muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Persistent erythropoiesis by myoblast transfer of erythropoietin cDNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Myoblast transfer of human erythropoietin gene in a mouse model of renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Muscle delivery of human kallikrein gene reduces blood pressure in hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Intramuscular delivery of rat kallikrein-binding protein gene reverses hypotension in transgenic mice expressing human tissue kallikrein

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Dystrophin: the protein product of the Duchenne muscular dystrophy locus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Immunoelectron microscopic localization of dystrophin in myofibres

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

The molecular basis of muscular dystrophy in the mdx mouse: a point mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Human myoblast transplantation: preliminary results of 4 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Myoblast transfer in Duchenne muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Gene transfer into skeletal muscles by isogenic myoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Myoblast transfer in the treatment of Duchenne's muscular dystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Rapid death of injected myoblasts in myoblast transfer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

The fate of individual myoblasts after transplantation into muscles of DMD patients

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Very efficient myoblast allotransplantation in mice under FK506 immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

The potential for gene therapy in Duchenne muscular dystrophy and other genetic muscle diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Adenovirus mediated expression of therapeutic plasma levels of human factor IX in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Differential short-term transduction efficiency of adult versus newborn mouse tissues by adenoviral recombinants.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Impairment of force generation after adenovirus-mediated gene transfer to muscle is alleviated by adenoviral gene inactivation and host CD8+ T cell deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Viral gene delivery to skeletal muscle: insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

LacZ gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Gene transfer to muscle using herpes simplex virus-based vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Encapsidated adenovirus minichromosomes allow delivery and expression of a 14 kb dystrophin cDNA to muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Stable incorporation of a bacterial gene into adult rat skeletal muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Retroviral-mediated transfer of a dystrophin minigene into mdx mouse myoblasts in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Replication-defective herpes simplex virus vectors for gene transfer in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Adenovirus as an expression vector in muscle cells in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Defective muscle basement membrane and lack of M-laminin in the dystrophic dy/dy mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Retroviral-mediated gene transfer into hepatocytes in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Myogenic cell lines derived from transgenic mice carrying a thermolabile T antigen: a model system for the derivation of tissue-specific and mutation-specific cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Culturing satellite cells from living single muscle fiber explants

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Myosin isoform transitions in regeneration of fast and slow muscles during postnatal development of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Cardiotoxin 1 from cobra (Naja naja atra) venom causes necrosis of skeletal muscle in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Immunosuppression by FK506 markedly prolongs expression of adenovirus-delivered transgene in skeletal muscles of adult dystrophic [mdx] mice

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Recombinant IL-12 prevents formation of blocking IgA antibodies to recombinant adenovirus and allows repeated gene therapy to mouse lung.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Prevention of immune reactions triggered by first-generation adenoviral vectors by monoclonal antibodies and CTLA4Ig

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Assembly of basement membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Gene transfer in regenerating muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021

Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0960-8966%2898%2900019-4

7 January 2021